Internal Medicine
Partner With Us
Advertisement

Rare Diseases

thumb description

July 03, 2025

Sonelokimab, Biologics Show Benefit in Hidradenitis Suppurativa

A systematic review and network meta-analysis of clinical trials found that several biologic and small-molecule therapies provided short-term improvement in adults with moderate to severe hidradenitis suppurativa, a chronic inflammatory skin disease.

Conexiant

thumb description

July 02, 2025

Gel Offers Relief for Axillary Sweating 

A pooled analysis of two phase 3 trials found that a once-daily topical anticholinergic gel significantly improved sweat reduction and symptom severity in patients with axillary hyperhidrosis, with a tolerable safety profile.

Conexiant

thumb description

July 02, 2025

Metabolic Syndrome Strongly Linked to Oral Diseases

New research highlights strong associations between metabolic syndrome and several oral diseases—including periodontitis, caries, and peri-implantitis—calling for more longitudinal studies to explore causation and improve patient care.

Conexiant

thumb description

July 01, 2025

Cough Syrup for Cognition Loss?

Once used for coughs, ambroxol is being investigated for Parkinson disease dementia. A new trial shows it is safe and biologically active, though cognitive benefits remain unproven.

Conexiant

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

thumb description

July 01, 2025

FDA Approves Low-IgA IG Therapy

GAMMAGARD LIQUID ERC is the first ready-to-use liquid immunoglobulin therapy with IgA ≤2 µg/mL for primary immunodeficiency in individuals aged 2 years and older.

Conexiant